ZAM
NVO

Zevin Asset Management’s Novo Nordisk NVO Stock Holding History

Zevin Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,017
Closed -$2.28M – 108
2025
Q3 		$2.28M Sell
41,017
-34,723
-46% -$2.03M 0.33% 45
2025
Q2 		$5.23M Sell
75,740
-8,951
-11% -$609K 0.75% 44
2025
Q1 		$5.88M Buy
84,691
+23,983
+40% +$1.98M 0.93% 41
2024
Q4 		$5.22M Buy
60,708
+19,416
+47% +$2.1M 0.77% 40
2024
Q3 		$4.92M Sell
41,292
-1,679
-4% -$224K 0.76% 41
2024
Q2 		$6.13M Buy
+42,971
New +$5.69M 0.99% 41
2017
Q1 		– Sell
-328,360
Closed -$5.89M – 121
2016
Q4 		$5.89M Sell
328,360
-38,740
-11% -$702K 1.54% 23
2016
Q3 		$7.63M Buy
367,100
+188,280
+105% +$4.67M 2.46% 14
2016
Q2 		$4.81M Buy
178,820
+1,150
+0.6% +$31.5K 1.33% 25
2016
Q1 		$4.81M Sell
177,670
-70,410
-28% -$1.89M 1.36% 24
2015
Q4 		$7.2M Buy
248,080
+5,300
+2% +$147K 1.9% 19
2015
Q3 		$6.58M Buy
242,780
+9,380
+4% +$266K 1.92% 18
2015
Q2 		$6.39M Buy
233,400
+118,050
+102% +$3.32M 1.7% 20
2015
Q1 		$3.08M Buy
115,350
+3,690
+3% +$85K 0.85% 40
2014
Q4 		$2.36M Sell
111,660
-30
-0% -$670 0.66% 54
2014
Q3 		$2.66M Buy
111,690
+2,000
+2% +$46K 0.78% 51
2014
Q2 		$2.53M Sell
109,690
-800
-0.7% -$17.7K 0.75% 47
2014
Q1 		$2.52M Sell
110,490
-350
-0.3% -$7.46K 0.8% 44
2013
Q4 		$2.05M Buy
110,840
+630
+0.6% +$11K 0.58% 51
2013
Q3 		$1.86M Buy
110,210
+4,610
+4% +$77.5K 0.57% 48
2013
Q2 		$1.64M Buy
+105,600
New +$1.76M 0.57% 51

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zevin Asset Management's NVO Position: Q4 2025 in Review

Zevin Asset Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 41,017 shares — an estimated $2.28M sold.

Zevin Asset Management first reported a position in NVO in Q2 2013 and held it in 21 quarters. The position peaked at $7.63M in Q3 2016. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Zevin Asset Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Zevin Asset Management sold 41,017 Novo Nordisk shares in Q4 2025, an estimated $2.28M.
  • Zevin Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 21 quarters.
  • Zevin Asset Management's Novo Nordisk position peaked at $7.63M in Q3 2016.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Zevin Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.